Home/Filings/4/0001600132-19-000160
4//SEC Filing

Tenenbaum Fabian 4

Accession 0001600132-19-000160

CIK 0001600132other

Filed

Nov 18, 7:00 PM ET

Accepted

Nov 19, 4:36 PM ET

Size

4.5 KB

Accession

0001600132-19-000160

Insider Transaction Report

Form 4
Period: 2019-11-15
Tenenbaum Fabian
Chief Executive Officer
Transactions
  • Tax Payment

    Common Stock

    2019-11-15$0.34/sh76,823$26,120407,459 total

Issuer

Bellerophon Therapeutics, Inc.

CIK 0001600132

Entity typeother

Related Parties

1
  • filerCIK 0001641300

Filing Metadata

Form type
4
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 4:36 PM ET
Size
4.5 KB